Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 18 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005739 | mitochondrion | 5 | 2 |
GO:0016020 | membrane | 2 | 8 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 8 |
Related structures:
AlphaFold database: Q4Q9Y0
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 5 |
GO:0016491 | oxidoreductase activity | 2 | 5 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_MEL_PAP_1 | 63 | 69 | PF00089 | 0.432 |
CLV_NRD_NRD_1 | 116 | 118 | PF00675 | 0.623 |
CLV_NRD_NRD_1 | 158 | 160 | PF00675 | 0.664 |
CLV_PCSK_SKI1_1 | 37 | 41 | PF00082 | 0.427 |
DOC_MAPK_gen_1 | 77 | 87 | PF00069 | 0.603 |
DOC_MAPK_MEF2A_6 | 77 | 86 | PF00069 | 0.607 |
DOC_PP4_FxxP_1 | 161 | 164 | PF00568 | 0.449 |
DOC_PP4_FxxP_1 | 40 | 43 | PF00568 | 0.624 |
DOC_PP4_FxxP_1 | 49 | 52 | PF00568 | 0.576 |
DOC_USP7_UBL2_3 | 118 | 122 | PF12436 | 0.420 |
DOC_WW_Pin1_4 | 128 | 133 | PF00397 | 0.418 |
LIG_14-3-3_CanoR_1 | 117 | 121 | PF00244 | 0.505 |
LIG_14-3-3_CanoR_1 | 66 | 72 | PF00244 | 0.644 |
LIG_EH_1 | 22 | 26 | PF12763 | 0.694 |
LIG_EH1_1 | 80 | 88 | PF00400 | 0.581 |
LIG_FHA_2 | 11 | 17 | PF00498 | 0.592 |
LIG_LIR_Apic_2 | 38 | 43 | PF02991 | 0.578 |
LIG_LIR_Gen_1 | 131 | 139 | PF02991 | 0.418 |
LIG_LIR_Gen_1 | 92 | 103 | PF02991 | 0.385 |
LIG_LIR_Nem_3 | 28 | 32 | PF02991 | 0.620 |
LIG_LIR_Nem_3 | 92 | 98 | PF02991 | 0.363 |
LIG_PDZ_Class_2 | 160 | 165 | PF00595 | 0.454 |
LIG_Pex14_2 | 25 | 29 | PF04695 | 0.661 |
LIG_SH2_SRC | 162 | 165 | PF00017 | 0.454 |
LIG_SH2_STAP1 | 142 | 146 | PF00017 | 0.428 |
LIG_SH2_STAP1 | 27 | 31 | PF00017 | 0.682 |
LIG_SH2_STAT5 | 162 | 165 | PF00017 | 0.454 |
LIG_SH3_3 | 36 | 42 | PF00018 | 0.667 |
LIG_SH3_3 | 4 | 10 | PF00018 | 0.643 |
LIG_SH3_3 | 76 | 82 | PF00018 | 0.610 |
LIG_TRAF2_2 | 52 | 57 | PF00917 | 0.591 |
LIG_UBA3_1 | 97 | 102 | PF00899 | 0.475 |
MOD_CK2_1 | 10 | 16 | PF00069 | 0.596 |
MOD_GlcNHglycan | 98 | 101 | PF01048 | 0.420 |
MOD_GSK3_1 | 112 | 119 | PF00069 | 0.485 |
MOD_N-GLC_1 | 128 | 133 | PF02516 | 0.618 |
MOD_NEK2_1 | 150 | 155 | PF00069 | 0.515 |
MOD_NEK2_1 | 25 | 30 | PF00069 | 0.680 |
MOD_PKA_2 | 116 | 122 | PF00069 | 0.505 |
MOD_PKA_2 | 65 | 71 | PF00069 | 0.627 |
MOD_Plk_4 | 104 | 110 | PF00069 | 0.443 |
MOD_Plk_4 | 58 | 64 | PF00069 | 0.618 |
MOD_ProDKin_1 | 128 | 134 | PF00069 | 0.419 |
MOD_SUMO_for_1 | 35 | 38 | PF00179 | 0.688 |
TRG_ER_diArg_1 | 17 | 20 | PF00400 | 0.600 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IGN0 | Leptomonas seymouri | 92% | 100% |
A0A0S4IVN1 | Bodo saltans | 70% | 100% |
A0A1X0NLX0 | Trypanosomatidae | 68% | 100% |
A0A1X0NML5 | Trypanosomatidae | 70% | 100% |
A0A3Q8IDG0 | Leishmania donovani | 99% | 100% |
A0A3R7LCN3 | Trypanosoma rangeli | 70% | 100% |
A4HE57 | Leishmania braziliensis | 95% | 100% |
A4I1F5 | Leishmania infantum | 99% | 100% |
C9ZK13 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 72% | 100% |
E9AXJ2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 98% | 100% |